Bisphosphonates and osteonecrosis of the jaw.

Suppr

超能文献

作者信息

Grey Andrew, Cundy Tim

出版信息

Ann Intern Med. 2006 Nov 21;145(10):791; author reply 792. doi: 10.7326/0003-4819-145-10-200611210-00021.

DOI:10.7326/0003-4819-145-10-200611210-00021

PMID:17116934

Abstract

摘要

相似文献

Bisphosphonates and osteonecrosis of the jaw.

Ann Intern Med. 2006 Nov 21;145(10):791; author reply 792. doi: 10.7326/0003-4819-145-10-200611210-00021.

Bisphosphonates and osteonecrosis of the jaw.

Ann Intern Med. 2006 Nov 21;145(10):791-2; author reply 792. doi: 10.7326/0003-4819-145-10-200611210-00022.

Oral bisphosphonates and osteonecrosis of the jaw.

Gen Dent. 2007 Jan-Feb;55(1):8-10.

Osteonecrosis of the jaws and bisphosphonates.

Alpha Omegan. 2007;100(4):194-202. doi: 10.1016/j.aodf.2007.10.013.

Beyond bisphosphonates: thrombophilia, hypofibrinolysis, and jaw osteonecrosis.

J Oral Maxillofac Surg. 2006 Nov;64(11):1704-5. doi: 10.1016/j.joms.2006.07.007.

Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention.

BMJ. 2006 Nov 11;333(7576):982-3. doi: 10.1136/bmj.39024.647558.BE.

[Osteonecrosis of the jaw].

Endokrynol Pol. 2011;62 Suppl 3:4-9.

Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.

J Mich Dent Assoc. 2005 Nov;87(11):40-2.

Osteonecrosis of the jaw in patients taking bisphosphonates.

Joint Bone Spine. 2006 Jan;73(1):7-9. doi: 10.1016/j.jbspin.2005.11.002. Epub 2005 Dec 9.

Osteonecrosis of the jaw in patients receiving oral bisphosphonates.

Osteoporos Int. 2010 Mar;21(3):535-6. doi: 10.1007/s00198-009-1089-5. Epub 2009 Oct 28.

引用本文的文献

Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene.

Expert Opin Pharmacother. 2011 Mar;12(4):657-74. doi: 10.1517/14656566.2011.557360. Epub 2011 Feb 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Bisphosphonates and osteonecrosis of the jaw.

Ann Intern Med. 2006 Nov 21;145(10):791; author reply 792. doi: 10.7326/0003-4819-145-10-200611210-00021.

Bisphosphonates and osteonecrosis of the jaw.

Ann Intern Med. 2006 Nov 21;145(10):791-2; author reply 792. doi: 10.7326/0003-4819-145-10-200611210-00022.

Oral bisphosphonates and osteonecrosis of the jaw.

Gen Dent. 2007 Jan-Feb;55(1):8-10.

Osteonecrosis of the jaws and bisphosphonates.

Alpha Omegan. 2007;100(4):194-202. doi: 10.1016/j.aodf.2007.10.013.

Beyond bisphosphonates: thrombophilia, hypofibrinolysis, and jaw osteonecrosis.

J Oral Maxillofac Surg. 2006 Nov;64(11):1704-5. doi: 10.1016/j.joms.2006.07.007.

Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention.

BMJ. 2006 Nov 11;333(7576):982-3. doi: 10.1136/bmj.39024.647558.BE.

[Osteonecrosis of the jaw].

Endokrynol Pol. 2011;62 Suppl 3:4-9.

Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.

J Mich Dent Assoc. 2005 Nov;87(11):40-2.

Osteonecrosis of the jaw in patients taking bisphosphonates.

Joint Bone Spine. 2006 Jan;73(1):7-9. doi: 10.1016/j.jbspin.2005.11.002. Epub 2005 Dec 9.

Osteonecrosis of the jaw in patients receiving oral bisphosphonates.

Osteoporos Int. 2010 Mar;21(3):535-6. doi: 10.1007/s00198-009-1089-5. Epub 2009 Oct 28.

引用本文的文献

Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene.

Expert Opin Pharmacother. 2011 Mar;12(4):657-74. doi: 10.1517/14656566.2011.557360. Epub 2011 Feb 7.